Generic Name : Carfilzomib
International- Kyprolis. Why it is prescribed (Indications) :
This medication is an antineoplastic agent, prescribed for multiple myeloma. It helps to slow the growth and spread of the cancer. When it is not to be taken (Contraindications): None.
Dosage & When it is to be taken :
IV- Cycle 1- The recommended dose is 20 mg/m².
If tolerated in Cycle 1, the dose should be increased to 27 mg/m² beginning in Cycle 2 and continued at 27 mg/m² in subsequent cycles. How it should be taken :
It comes as a powder for injection (diluted with fluid) to be administered by a healthcare provider into the vein. Warnings and Precautions :
* Caution should be exercised in patients with history of heart arrest, congestive heart failure, high blood pressure, any allergy, who are taking other medications, during pregnancy and breastfeeding.
* It may cause fatigue, dizziness, fainting, and/or low blood pressure, do not drive a car or operate machinery while taking this medication.
* Patient may experience shortness of breath, if it is so consult with your healthcare provider. Side Effects :
Fatigue, anemia, nausea, decrease in platelets, difficulty in breathing, diarrhea, and fever.
* Avoid excess dosage. Storage Conditions :
Store it in refrigerator (2°C to 8°C).
Comment & Contribute
Ask an Expert